Patients with hepatocellular carcinoma that die during the first year of liver transplantation have high blood sFasL concentrations

Figure 1 Receiver operation characteristic of serum soluble FasL levels previously to liver transplantation due to hepatocellular carcinoma for the prediction of one-year liver transplantation mortality. Area under curve of serum soluble FasL (sFasL) levels and sensitivity/specificity of serum sFasL levels > 190 pg/mL are reported. AUC: Area under curve; sFasL: Soluble FasL.